Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by James J. Burns & Company LLC

James J. Burns & Company LLC trimmed its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 29.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,429 shares of the company's stock after selling 4,286 shares during the quarter. James J. Burns & Company LLC's holdings in Henry Schein were worth $714,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of HSIC. Investment Management Corp VA ADV bought a new stake in shares of Henry Schein during the 4th quarter worth $32,000. Venturi Wealth Management LLC lifted its stake in shares of Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after acquiring an additional 569 shares during the last quarter. Quent Capital LLC boosted its holdings in Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after acquiring an additional 323 shares during the period. Smartleaf Asset Management LLC lifted its position in Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after purchasing an additional 143 shares during the last quarter. Finally, Allworth Financial LP boosted its stake in shares of Henry Schein by 180.7% during the fourth quarter. Allworth Financial LP now owns 946 shares of the company's stock valued at $71,000 after purchasing an additional 609 shares during the period. 96.62% of the stock is owned by institutional investors.

Henry Schein Trading Up 0.9%

Shares of HSIC traded up $0.66 during trading hours on Wednesday, reaching $71.23. 454,843 shares of the company traded hands, compared to its average volume of 1,676,270. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The stock's fifty day moving average price is $67.67 and its 200 day moving average price is $71.69. The firm has a market cap of $8.67 billion, a price-to-earnings ratio of 29.31, a PEG ratio of 2.13 and a beta of 0.87. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. During the same quarter last year, the firm earned $1.10 EPS. The business's quarterly revenue was down .1% on a year-over-year basis. Sell-side analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. UBS Group decreased their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Wells Fargo & Company decreased their price objective on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Wall Street Zen cut Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Piper Sandler dropped their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 30th. Finally, Barrington Research decreased their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research note on Tuesday, May 6th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $79.30.

Insiders Place Their Bets

In related news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.08% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.